SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 157 filers reported holding SERES THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,385 | -40.7% | 53,943 | +19.3% | 0.00% | – |
| Q2 2023 | $216,532 | +2.7% | 45,205 | +21.5% | 0.00% | – |
| Q1 2023 | $210,878 | -9.6% | 37,192 | -10.7% | 0.00% | – |
| Q4 2022 | $233,256 | +74.1% | 41,653 | +99.5% | 0.00% | – |
| Q3 2022 | $134,000 | +83.6% | 20,882 | -1.7% | 0.00% | – |
| Q2 2022 | $73,000 | -55.5% | 21,243 | -7.9% | 0.00% | – |
| Q1 2022 | $164,000 | -13.2% | 23,057 | +1.4% | 0.00% | – |
| Q4 2021 | $189,000 | -17.8% | 22,742 | -31.4% | 0.00% | – |
| Q3 2021 | $230,000 | -83.2% | 33,140 | -42.4% | 0.00% | -100.0% |
| Q2 2021 | $1,371,000 | +13.6% | 57,519 | -1.8% | 0.00% | 0.0% |
| Q1 2021 | $1,207,000 | +51.8% | 58,583 | +80.7% | 0.00% | 0.0% |
| Q4 2020 | $795,000 | +250.2% | 32,424 | +304.7% | 0.00% | – |
| Q3 2020 | $227,000 | – | 8,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $142,936,000 | 37.99% |
| ARK Investment Management | 629,915 | $7,099,000 | 2.05% |
| Artal Group S.A. | 600,000 | $6,762,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,479,000 | 0.14% |
| Opus Point Partners Management, LLC | 14,000 | $158,000 | 0.12% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $168,000 | 0.08% |
| Virtus ETF Advisers LLC | 31,133 | $351,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 12,100 | $136,000 | 0.06% |
| Acrospire Investment Management LLC | 4,470 | $50,000 | 0.04% |
| Spark Investment Management LLC | 54,400 | $613,000 | 0.04% |